论文部分内容阅读
目的探讨低分子肝素钙联合尿激酶在进展性脑梗死患者治疗中的疗效。方法选择本院100例进展性脑梗死患者,上述患者随机分为观察组和对照组,观察组和对照组均给予常规治疗,观察组同时给予低分子肝素钙和小剂量尿激酶治疗。治疗前和治疗后进行神经功能缺损评分,根据评分增减情况进行疗效评定。结果观察组和对照组治疗过程中未出现严重不良反应,观察组总有效率为96.0%;对照组总有效率为80.0%,观察组总有效率高于对照组,差异有统计学意义(P<0.05)。结论低分子肝素钙联合尿激酶在进展性脑梗死患者治疗中的疗效显著,值得借鉴。
Objective To investigate the effect of low molecular weight heparin combined with urokinase in the treatment of patients with progressive cerebral infarction. Methods A total of 100 patients with progressive cerebral infarction in our hospital were enrolled. The above patients were randomly divided into observation group and control group. The observation group and control group were given routine treatment. The observation group received both low molecular weight heparin and low dose of urokinase. Neurological deficits were assessed before treatment and after treatment, and the curative effect was evaluated according to the change of score. Results The observation group and the control group had no serious adverse reactions during the course of treatment. The total effective rate was 96.0% in the observation group and 80.0% in the control group. The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). Conclusion low molecular weight heparin with urokinase in patients with progressive cerebral infarction in the treatment of significant effect, it is worth learning.